Citigroup’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130K Sell
4,801
-2,400
-33% -$80.7K ﹤0.01% 4190
2025
Q4
$308K Buy
7,201
+3,366
+88% +$127K ﹤0.01% 3804
2025
Q3
$109K Sell
3,835
-7,929
-67% -$237K ﹤0.01% 4238
2025
Q2
$220K Sell
11,764
-18,408
-61% -$349K ﹤0.01% 4017
2025
Q1
$543K Buy
30,172
+15,317
+103% +$311K ﹤0.01% 3633
2024
Q4
$250K Buy
14,855
+1,498
+11% +$28.7K ﹤0.01% 4275
2024
Q3
$216K Buy
13,357
+9,107
+214% +$107K ﹤0.01% 4287
2024
Q2
$34.9K Buy
4,250
+1,004
+31% +$10.5K ﹤0.01% 4784
2024
Q1
$48K Buy
3,246
+438
+16% +$5.9K ﹤0.01% 4647
2023
Q4
$40.7K Buy
2,808
+2,798
+27,980% +$28.6K ﹤0.01% 4628
2023
Q3
$107 Sell
10
-5,088
-100% -$61.2K ﹤0.01% 5404
2023
Q2
$65.8K Sell
5,098
-7,308
-59% -$98.8K ﹤0.01% 4478
2023
Q1
$164K Buy
12,406
+10,081
+434% +$160K ﹤0.01% 3833
2022
Q4
$34.9K Sell
2,325
-1,097
-32% -$10.1K ﹤0.01% 4381
2022
Q3
$40K Sell
3,422
-153,880
-98% -$2.08M ﹤0.01% 4485
2022
Q2
$1.78M Buy
157,302
+147,358
+1,482% +$2.96M ﹤0.01% 2194
2022
Q1
$297K Sell
9,944
-31,106
-76% -$842K ﹤0.01% 3846
2021
Q4
$1.09M Buy
41,050
+19,585
+91% +$591K ﹤0.01% 3160
2021
Q3
$779K Sell
21,465
-42,456
-66% -$1.67M ﹤0.01% 3283
2021
Q2
$2.77M Sell
63,921
-13,583
-18% -$513K ﹤0.01% 2400
2021
Q1
$2.65M Buy
77,504
+55,449
+251% +$2.2M ﹤0.01% 2296
2020
Q4
$772K Buy
22,055
+20,129
+1,045% +$583K ﹤0.01% 3802
2020
Q3
$46K Sell
1,926
-4,517
-70% -$111K ﹤0.01% 5663
2020
Q2
$118K Sell
6,443
-2,194
-25% -$39.5K ﹤0.01% 5444
2020
Q1
$135K Buy
8,637
+3,159
+58% +$67.2K ﹤0.01% 5085
2019
Q4
$117K Sell
5,478
-14,514
-73% -$299K ﹤0.01% 5627
2019
Q3
$374K Sell
19,992
-439
-2% -$9.07K ﹤0.01% 4613
2019
Q2
$533K Buy
20,431
+778
+4% +$17.6K ﹤0.01% 4356
2019
Q1
$505K Sell
19,653
-58,831
-75% -$1.35M ﹤0.01% 4171
2018
Q4
$1.8M Buy
78,484
+9,811
+14% +$277K ﹤0.01% 2769
2018
Q3
$2.2M Sell
68,673
-22,899
-25% -$687K ﹤0.01% 2636
2018
Q2
$2.59M Sell
91,572
-7,441
-8% -$265K ﹤0.01% 2455
2018
Q1
$3.5M Buy
99,013
+81,203
+456% +$3.25M 0.01% 2097
2017
Q4
$691K Buy
17,810
+17,388
+4,120% +$662K ﹤0.01% 3745
2017
Q3
$10K Sell
422
-231
-35% -$5.62K ﹤0.01% 6697
2017
Q2
$18K Sell
653
-1,223
-65% -$33.5K ﹤0.01% 6318
2017
Q1
$63K Sell
1,876
-32,093
-94% -$818K ﹤0.01% 5546
2016
Q4
$808K Buy
33,969
+21,888
+181% +$627K ﹤0.01% 3907
2016
Q3
$443K Buy
12,081
+10,045
+493% +$288K ﹤0.01% 4001
2016
Q2
$45K Sell
2,036
-6,357
-76% -$158K ﹤0.01% 5631
2016
Q1
$174K Buy
8,393
+4,527
+117% +$112K ﹤0.01% 5217
2015
Q4
$117K Buy
3,866
+3,854
+32,117% +$117K ﹤0.01% 5254
2015
Q3
$0 Sell
12
-148
-93% -$4.42K ﹤0.01% 7656
2015
Q2
$5K Sell
160
-396
-71% -$15.1K ﹤0.01% 6772
2015
Q1
$19K Sell
556
-1,196
-68% -$32.8K ﹤0.01% 6120
2014
Q4
$40K Buy
1,752
+1,448
+476% +$29.3K ﹤0.01% 5835
2014
Q3
$6K Sell
304
-708
-70% -$20K ﹤0.01% 6500
2014
Q2
$37K Sell
1,012
-1,371
-58% -$46.6K ﹤0.01% 5379
2014
Q1
$92K Sell
2,383
-2,043
-46% -$72.8K ﹤0.01% 5065
2013
Q4
$127K Buy
4,426
+769
+21% +$22.6K ﹤0.01% 5049
2013
Q3
$130K Sell
3,657
-547
-13% -$20K ﹤0.01% 4516
2013
Q2
$140K Buy
+4,204
New +$190K ﹤0.01% 4574

Other funds holding RIGL